Personalized Preventive Medicine: Genetics and the Response to Regular Exercise in Preventive Interventions

Progress in Cardiovascular Diseases

Volumn 57, Issue 4, 2015, Pages 337-346

  Bouchard, Claude ^a   Antunes Correa, Ligia M ^b   Ashley, Euan A ^c,d   Franklin, Nina ^e   Hwang, Paul M ^f   Mattsson, C Mikael ^c,g   Negrao, Carlos E ^b   Phillips, Shane A ^e   Sarzynski, Mark A ^a   Wang, Ping yuan ^f   Wheeler, Matthew T ^c,d  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g SWEDISH SCHOOL OF SPORT AND HEALTH SCIENCES   (Sweden)

Author keywords

Endothelium; Genetics; Individual differences; Mitochondria; Personalized medicine

Indexed keywords

PROTEIN P53;

AEROBIC EXERCISE; ARTICLE; EXERCISE; GENETIC ASSOCIATION; GENETIC DIFFERENCE; HEART DISEASE; HUMAN; MOLECULAR GENETICS; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; MYOPATHY; NONHUMAN; PERSONALIZED MEDICINE; PREVENTIVE MEDICINE; SEDENTARY LIFESTYLE; ADAPTATION; ANIMAL; CARDIOVASCULAR DISEASES; EXERCISE TOLERANCE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; KINESIOTHERAPY; METABOLISM; MOTOR ACTIVITY; MOUSE; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SKELETAL MUSCLE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARDIOVASCULAR DISEASES; EXERCISE; EXERCISE THERAPY; EXERCISE TOLERANCE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICE; MOTOR ACTIVITY; MUSCLE, SKELETAL; MUTATION; PRECISION MEDICINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84920152411     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.08.005     Document Type: Article

References (92)

1. Morris J.N., Heady J.A., Raffle P.A., et al. Coronary heart-disease and physical activity of work. Lancet 1953, 265:1111-1120. [concl, 1953].
2. Morris J.N., Heady J.A., Raffle P.A., et al. Coronary heart-disease and physical activity of work. Lancet 1953, 265:1053-1057. [contd, 1953].
3. Blair S.N., Kohl H.W., Barlow C.E., et al. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 1995, 273:1093-1098.
4. Blair S.N., Kohl H.W., Paffenbarger R.S., et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989, 262:2395-2401.
5. Hooker S.P., Sui X., Colabianchi N., et al. Cardiorespiratory fitness as a predictor of fatal and nonfatal stroke in asymptomatic women and men. Stroke 2008, 39:2950-2957.
6. Jones L.W., Watson D., Herndon J.E., et al. Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. Cancer 2010, 116:4825-4832.
7. Katzmarzyk P.T., Church T.S., Craig C.L., et al. Sitting time and mortality from all causes, cardiovascular disease, and cancer. Med Sci Sports Exerc 2009, 41:998-1005.
8. Kodama S., Saito K., Tanaka S., et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009, 301:2024-2035.
9. McAuley P., Pittsley J., Myers J., et al. Fitness and fatness as mortality predictors in healthy older men: the veterans exercise testing study. J Gerontol A Biol Sci Med Sci 2009, 64:695-699.
10. Paffenbarger R.S., Hyde R.T., Wing A.L., et al. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986, 314:605-613.
11. Sui X., Lee D.C., Matthews C.E., et al. Influence of cardiorespiratory fitness on lung cancer mortality. Med Sci Sports Exerc 2010, 42:872-878.
12. Church T.S., Blair S.N., Cocreham S., et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA 2010, 304:2253-2262.
13. Church T.S., Earnest C.P., Skinner J.S., et al. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 2007, 297:2081-2091.
14. Kelley G.A., Kelley K.S. Efficacy of aerobic exercise on coronary heart disease risk factors. Prev Cardiol 2008, 11:71-75.
15. Nikander R., Sievanen H., Heinonen A., et al. Targeted exercise against osteoporosis: A systematic review and meta-analysis for optimising bone strength throughout life. BMC Med 2010, 8:47.
16. Valkeinen H., Aaltonen S., Kujala U.M. Effects of exercise training on oxygen uptake in coronary heart disease: a systematic review and meta-analysis. Scand J Med Sci Sports 2010, 20:545-555.
17. Lortie G., Simoneau J.A., Hamel P., et al. Responses of maximal aerobic power and capacity to aerobic training. Int J Sports Med 1984, 5:232-236.
18. Bouchard C., An P., Rice T., et al. Familial aggregation of VO(2max) response to exercise training: results from the HERITAGE Family Study1. J Appl Physiol 1999, 87:1003-1008.
19. Ashley E.A., Butte A.J., Wheeler M.T., et al. Clinical assessment incorporating a personal genome. Lancet 2010, 375:1525-1535.
20. Dewey F.E., Chen R., Cordero S.P., et al. Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet 2011, 7:e1002280.
21. Chen R., Mias G.I., Li-Pook-Than J., et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012, 148:1293-1307.
22. Welter D., MacArthur J., Morales J., et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014, 42:D1001-D1006.
23. Buford T.W., Roberts M.D., Church T.S. Toward exercise as personalized medicine. Sports Med 2013, 43:157-165.
24. de la Chapelle A., Traskelin A.L., Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci U S A 1993, 90:4495-4499.
25. Maron B.J., Chaitman B.R., Ackerman M.J., et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004, 109:2807-2816.
26. Barabasi A.L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011, 12:56-68.
27. Bouchard C. Human adaptability May have a genetic basis. Health risk estimation, risk reduction and health promotion. Proceedings of the 18th annual meeting of the Society of Prospective Medicine 1983, 463-476. Canadian Public Health Association, Ottawa. F. Landry (Ed.).
28. Despres J.P., Bouchard C., Savard R., et al. The effect of a 20-week endurance training program on adipose-tissue morphology and lipolysis in men and women. Metabolism 1984, 33:235-239.
29. Savard R., Despres J.P., Marcotte M., et al. Endurance training and glucose conversion into triglycerides in human fat cells. J Appl Physiol 1985, 58:230-235.
30. Hamel P., Simoneau J.A., Lortie G., et al. Heredity and muscle adaptation to endurance training. Med Sci Sports Exerc 1986, 18:690-696.
31. Simoneau J.A., Lortie G., Boulay M.R., et al. Inheritance of human skeletal muscle and anaerobic capacity adaptation to high-intensity intermittent training. Int J Sports Med 1986, 7:167-171.
32. Bouchard C., Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc 2001, 33:S446-S451.
33. Skinner J.S., Wilmore K.M., Krasnoff J.B., et al. Adaptation to a standardized training program and changes in fitness in a large, heterogeneous population: the HERITAGE Family Study. Med Sci Sports Exerc 2000, 32:157-161.
34. Wilmore J.H., Stanforth P.R., Gagnon J., et al. Cardiac output and stroke volume changes with endurance training: the HERITAGE Family Study. Med Sci Sports Exerc 2001, 33:99-106.
35. Despres J.P., Bouchard C., Savard R., et al. Adaptive changes to training in adipose tissue lipolysis are genotype dependent. Int J Obes 1984, 8:87-95.
36. Prud'homme D., Bouchard C., Leblanc C., et al. Sensitivity of maximal aerobic power to training is genotype-dependent. Med Sci Sports Exerc 1984, 16:489-493.
37. Bouchard C., Tremblay A., Despres J.P., et al. The response to exercise with constant energy intake in identical twins. Obes Res 1994, 2:400-410.
38. Boulay M.R., Lortie G., Simoneau J.A., et al. Sensitivity of maximal aerobic power and capacity to anaerobic training is partly genotype dependent. Sport and human genetics 1986, 173-181. Human Kinetics, Champaign, IL. R.M. Malina, C. Bouchard (Eds.).
39. Rankinen T., An P., Perusse L., et al. Genome-wide linkage scan for exercise stroke volume and cardiac output in the HERITAGE Family Study1. Physiol Genomics 2002, 10:57-62.
40. Spielmann N., Leon A.S., Rao D.C., et al. Genome-wide linkage scan for submaximal exercise heart rate in the HERITAGE family study. Am J Physiol Heart Circ Physiol 2007, 293:H3366-H3371.
41. Argyropoulos G., Stutz A.M., Ilnytska O., et al. KIF5B gene sequence variation and response of cardiac stroke volume to regular exercise. Physiol Genomics 2009, 36:79-88.
42. Rankinen T., Argyropoulos G., Rice T., et al. CREB1 is a strong genetic predictor of the variation in exercise heart rate response to regular exercise: the HERITAGE Family Study. Circ Cardiovasc Genet 2010, 3:294-299.
43. Bouchard C., Sarzynski M.A., Rice T.K., et al. Genomic predictors of the maximal O uptake response to standardized exercise training programs. J Appl Physiol 2011, 110:1160-1170.
44. De S., Kumari J., Mudgal R., et al. RECQL4 is essential for the transport of p53 to mitochondria in normal human cells in the absence of exogenous stress. J Cell Sci 2012, 125:2509-2522.
45. Zhuang J., Wang P.Y., Huang X., et al. Mitochondrial disulfide relay mediates translocation of p53 and partitions its subcellular activity. Proc Natl Acad Sci U S A 2013, 110:17356-17361.
46. Lago C.U., Sung H.J., Ma W., et al. p53, aerobic metabolism, and cancer. Antioxid Redox Signal 2011, 15:1739-1748.
47. Matoba S., Kang J.G., Patino W.D., et al. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
48. Park J.Y., Wang P.Y., Matsumoto T., et al. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ Res 2009, 105:705-712. [711 p following 712].
49. Saleem A., Adhihetty P.J., Hood D.A. Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle. Physiol Genomics 2009, 37:58-66.
50. Malkin D., Li F.P., Strong L.C., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990, 250:1233-1238.
51. Chance B., Im J., Nioka S., et al. Skeletal muscle energetics with PNMR: personal views and historic perspectives. NMR Biomed 2006, 19:904-926.
52. Wang P.Y., Ma W., Park J.Y., et al. Increased oxidative metabolism in the Li-Fraumeni syndrome. N Engl J Med 2013, 368:1027-1032.
53. Bergeaud M., Mathieu L., Guillaume A., et al. Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F(1)F0-ATP synthase. Cell Cycle 2013, 12:2781-2793.
54. Laufs U., Wassmann S., Czech T., et al. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis. Arterioscler Thromb Vasc Biol 2005, 25:809-814.
55. Gokce N., Keaney J.F., Hunter L.M., et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 2002, 105:1567-1572.
56. Vanhoutte P.M., Shimokawa H., Tang E.H., et al. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 2009, 196:193-222.
57. Nyberg M., Blackwell J.R., Damsgaard R., et al. Lifelong physical activity prevents an age-related reduction in arterial and skeletal muscle nitric oxide bioavailability in humans. J Physiol 2012, 590:5361-5370.
58. Myers J., Prakash M., Froelicher V., et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002, 346:793-801.
59. Clarkson P., Montgomery H.E., Mullen M.J., et al. Exercise training enhances endothelial function in young men. J Am Coll Cardiol 1999, 33:1379-1385.
60. Harris R.A., Padilla J., Hanlon K.P., et al. The flow-mediated dilation response to acute exercise in overweight active and inactive men. Obesity (Silver Spring) 2008, 16:578-584.
61. Jurva J.W., Phillips S.A., Syed A.Q., et al. The effect of exertional hypertension evoked by weight lifting on vascular endothelial function. J Am Coll Cardiol 2006, 48:588-589.
62. MacDougall J.D., Tuxen D., Sale D.G., et al. Arterial blood pressure response to heavy resistance exercise. J Appl Physiol 1985, 58:785-790. [1985].
63. Phillips S.A., Das E., Wang J., et al. Resistance and aerobic exercise protects against acute endothelial impairment induced by a single exposure to hypertension during exertion. J Appl Physiol 2011, 110:1013-1020.
64. Currie K.D., McKelvie R.S., Macdonald M.J. Flow-mediated dilation is acutely improved after high-intensity interval exercise. Med Sci Sports Exerc 2012, 44:2057-2064.
65. Tinken T.M., Thijssen D.H., Hopkins N., et al. Shear stress mediates endothelial adaptations to exercise training in humans. Hypertension 2010, 55:312-318.
66. Goto C., Higashi Y., Kimura M., et al. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress. Circulation 2003, 108:530-535.
67. Vona M., Rossi A., Capodaglio P., et al. Impact of physical training and detraining on endothelium-dependent vasodilation in patients with recent acute myocardial infarction. Am Heart J 2004, 147:1039-1046.
68. Hambrecht R., Fiehn E., Weigl C., et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998, 98:2709-2715.
69. Hambrecht R., Adams V., Erbs S., et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003, 107:3152-3158.
70. Adams V., Linke A., Krankel N., et al. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation 2005, 111:555-562.
71. Wisloff U., Stoylen A., Loennechen J.P., et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007, 115:3086-3094.
72. Belardinelli R., Lacalaprice F., Ventrella C., et al. Waltz dancing in patients with chronic heart failure: new form of exercise training. Circ Heart Fail 2008, 1:107-114.
73. Miura H., Bosnjak J.J., Ning G., et al. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 2003, 92:e31-e40.
74. Matoba T., Shimokawa H., Nakashima M., et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 2000, 106:1521-1530.
75. Phillips S.A., Bian J.T., Church E.C., et al. Hydrogen peroxide prevents impaired endothelium-dependent dilation following acute exertion in chronic exercising but not in sedentary subjects. Circulation 2009, 120. [S1013-S1013].
76. Rush J.W., Laughlin M.H., Woodman C.R., et al. SOD-1 expression in pig coronary arterioles is increased by exercise training. Am J Physiol Heart Circ Physiol 2000, 279:H2068-H2076.
77. Albert C.M., Mittleman M.A., Chae C.U., et al. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000, 343:1355-1361.
78. Rolim N.P., Medeiros A., Rosa K.T., et al. Exercise training improves the net balance of cardiac Ca2+ handling protein expression in heart failure. Physiol Genomics 2007, 29:246-252.
79. Oliveira R.S., Ferreira J.C., Gomes E.R., et al. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. J Physiol 2009, 587:3899-3910.
80. Campos J.C., Queliconi B.B., Dourado P.M., et al. Exercise training restores cardiac protein quality control in heart failure. PLoS One 2012, 7:e52764.
81. Antunes-Correa L.M., Kanamura B.Y., Melo R.C., et al. Exercise training improves neurovascular control and functional capacity in heart failure patients regardless of age. Eur J Prev Cardiol 2012, 19:822-829.
82. Soares-Miranda L., Franco F.G., Roveda F., et al. Effects of exercise training on neurovascular responses during handgrip exercise in heart failure patients. Int J Cardiol 2011, 146:122-125.
83. Gielen S., Adams V., Mobius-Winkler S., et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 2003, 42:861-868.
84. Bacurau A.V., Jardim M.A., Ferreira J.C., et al. Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training. J Appl Physiol 2009, 106:1631-1640.
85. Cunha T.F., Bacurau A.V., Moreira J.B., et al. Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure. PLoS One 2012, 7:e41701.
86. Hambrecht R., Schulze P.C., Gielen S., et al. Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005, 12:401-406.
87. Lenk K., Erbs S., Hollriegel R., et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol 2012, 19:404-411.
88. Barretto A.C., Santos A.C., Munhoz R., et al. Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol 2009, 135:302-307.
89. Fiuza-Luces C., Garatachea N., Berger N.A., et al. Exercise is the real polypill. Physiology (Bethesda) 2013, 28:330-358.
90. Powers S.K., Smuder A.J., Kavazis A.N., et al. Mechanisms of exercise-induced cardioprotection. Physiology (Bethesda) 2014, 29:27-38.
91. Hoppeler H., Baum O., Lurman G., et al. Molecular mechanisms of muscle plasticity with exercise. Comp Physiol 2011, 1:1383-1412.
92. Ghosh S., Vivar J.C., Sarzynski M.A., et al. Integrative pathway analysis of a genome-wide association study of (V)O(2max) response to exercise training. J Appl Physiol 2013, 115:1343-1359.